View as Webpage

Does respiratory tract infection always cause by SARS-CoV-2 or Influenza?

In addition to SARS-CoV-2 and influenza, the human respiratory syncytial virus (HRSV), is also one of the main causes of acute lower respiratory tract infections. However, treatment methods for HRSV are still very limited, and there has been no approved HRSV vaccine so far. Therefore, RSV prevention and treatment products need to be developed urgently.


ACROBiosystems developed pre- and post-fusion Glycoprotein G & F, supporting the HRSV vaccine and therapeutics R&D!

★ Features

-     Expressed by HEK293 cells, the protein structure is closer to the natural conformation;

-     Provide Glycoprotein G, Pre-fusion and Post-fusion Glycoprotein F;

-     Over 90% purity verified by SDS-PAGE and MALS;

-     Binding activity with antibodies verified by ELISA assay;

-     High immunogenicity: can induce higher antibody titers.

★ Product List

Click to find out more
Find more about other infectious diseases

Upcoming Conferences

To receive the latest industry news and updates from ACROBiosystems,

visit our website & follow us on our social media!

Visit our Website
LinkedIn  Twitter  YouTube  Facebook